Skip to main content
Top
Published in: International Journal of Legal Medicine 1/2019

01-01-2019 | Case Report

Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700

Authors: Camille Richeval, Jean-Michel Gaulier, Ludovic Romeuf, Delphine Allorge, Yvan Gaillard

Published in: International Journal of Legal Medicine | Issue 1/2019

Login to get access

Abstract

Today, new psychoactive substances (NPS) producers increasingly appear to be targeting new synthetic opioids (NSOs), and the recent emergence of NSOs is causing considerable concern in North America and in Europe. For toxicologists, NSO detection in a forensic context presents three additional difficulties to the general NPS analytical detection challenge: (i) high frequency of new products, (ii) low concentrations (in μg/L range and under) in biological samples related to their high opioid potency, and (iii) extensive metabolism. In this context, the present work aims to highlight the relevance of NSO metabolite detection in potential intoxication cases. Illustration is given with U-47700, an emerging NSO, (i) that was identified in a powder recently collected in France and in a fatality case, (ii) whose metabolites were in vitro produced using human liver microsomes and their mass spectra (MS) added in our MS/MS and HRMS libraries, and (iii) for which metabolism data were compared to those of the literature: U-47700 was identified in the powder and at 3040 μg/L in peripheral blood in the fatality case. In addition, high amounts of several U-47700 metabolites, especially N-desmethyl-U-47700, were observed in urine. Even if metabolite formation may largely depend on the enzymatic activity as well as on the length of the survival time, confrontation of these results to data found in the literature strongly suggests that this metabolite is regularly a better blood and (mainly) urine biomarker of U-47700 intake than U-47700 itself. Indeed, in this fatality and in other previous reports, N-desmethyl-U-47700 produced the main observed chromatographic signal (i) systematically in vitro and (ii) commonly in vivo, especially in urines. N,N-Didesmethyl-U-47700 is also sometimes a better biomarker of U-47700 intake than U-47700 itself. Accordingly, we suggest adding N-desmethyl-U-47700 (and N,N-didesmethyl-U-47700) in mass spectrum databases used for toxicological screening in order to reduce the risk of false-negative results in intoxication cases involving U-47700.
Literature
1.
go back to reference EMCDDA (2017) European Drug Report 2017: Trends and Developments. Publications Office of the European Union, Luxembourg EMCDDA (2017) European Drug Report 2017: Trends and Developments. Publications Office of the European Union, Luxembourg
7.
go back to reference Cheney BV, Szmuszkovicz J, Lahti RA, Zichi DA (1985) Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzamides at the primary morphine receptor. J Med Chem 28:1853–1864CrossRefPubMed Cheney BV, Szmuszkovicz J, Lahti RA, Zichi DA (1985) Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzamides at the primary morphine receptor. J Med Chem 28:1853–1864CrossRefPubMed
15.
go back to reference Drug Enforcement Administration, Department of Justice (2016) Schedules of Controlled Substances: Temporary Placement of U-47700 Into Schedule I. Final Order Fed Regist 81(219):79389–79393 Drug Enforcement Administration, Department of Justice (2016) Schedules of Controlled Substances: Temporary Placement of U-47700 Into Schedule I. Final Order Fed Regist 81(219):79389–79393
21.
go back to reference UNODC (2017) World Drug Report 2017 (ISBN: 978–92–1-148291-1, eISBN: 978–92–1-060623-3, United Nations publication, Sales No. E.17.XI.6) UNODC (2017) World Drug Report 2017 (ISBN: 978–92–1-148291-1, eISBN: 978–92–1-060623-3, United Nations publication, Sales No. E.17.XI.6)
23.
go back to reference Kronstrand R, Brinkhagen L, Birath-Karlsson C, Roman M, Josefsson M (2014) LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine. Anal Bioanal Chem 406:3599–3609CrossRefPubMed Kronstrand R, Brinkhagen L, Birath-Karlsson C, Roman M, Josefsson M (2014) LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine. Anal Bioanal Chem 406:3599–3609CrossRefPubMed
24.
go back to reference Watanabe S, Vikingsson S, Roman M, Green H, Kronstrand R, Wohlfarth A (2107) In vitro and in vivo metabolite identification studies for the new synthetic opioids acetylfentanyl, acrylfentanyl, furanylfentanyl, and 4-fluoro-isobutyrylfentanyl. AAPS J 19(4):1102–1122. https://doi.org/10.1208/s12248-017-0070-z CrossRef Watanabe S, Vikingsson S, Roman M, Green H, Kronstrand R, Wohlfarth A (2107) In vitro and in vivo metabolite identification studies for the new synthetic opioids acetylfentanyl, acrylfentanyl, furanylfentanyl, and 4-fluoro-isobutyrylfentanyl. AAPS J 19(4):1102–1122. https://​doi.​org/​10.​1208/​s12248-017-0070-z CrossRef
26.
go back to reference Richeval C, Gicquel T, Hugbart C, Le Dare B, Allorge D, Morel I, Gaulier JM (2017) In vitro characterization of NPS metabolites produced by human liver microsomes and the HepaRG cell line using liquid chromatography-high resolution mass spectrometry (LC-HRMS) analysis: application to furanyl fentanyl. Curr Pharm Biotechnol 18(10):806–814. https://doi.org/10.2174/1389201018666171122124401 CrossRefPubMed Richeval C, Gicquel T, Hugbart C, Le Dare B, Allorge D, Morel I, Gaulier JM (2017) In vitro characterization of NPS metabolites produced by human liver microsomes and the HepaRG cell line using liquid chromatography-high resolution mass spectrometry (LC-HRMS) analysis: application to furanyl fentanyl. Curr Pharm Biotechnol 18(10):806–814. https://​doi.​org/​10.​2174/​1389201018666171​122124401 CrossRefPubMed
29.
go back to reference Krotulski AJ, Mohr ALA, Papsun DM, Logan BK (2018) Metabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug users. Drug Test Anal 10(1):127–136CrossRefPubMed Krotulski AJ, Mohr ALA, Papsun DM, Logan BK (2018) Metabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug users. Drug Test Anal 10(1):127–136CrossRefPubMed
31.
32.
go back to reference Carlier J, Guitton J, Romeuf L, Bévalot F, Boyer B, Fanton L, Gaillard Y (2015) Screening approach by ultra-high performance liquid chromatography-tandem mass spectrometry for the blood quantification of thirty-four toxic principles of plant origin. Application to forensic toxicology. J Chromatogr B Anal Technol Biomed Life Sci 975:65–76. https://doi.org/10.1016/j.jchromb.2014.10.028 CrossRef Carlier J, Guitton J, Romeuf L, Bévalot F, Boyer B, Fanton L, Gaillard Y (2015) Screening approach by ultra-high performance liquid chromatography-tandem mass spectrometry for the blood quantification of thirty-four toxic principles of plant origin. Application to forensic toxicology. J Chromatogr B Anal Technol Biomed Life Sci 975:65–76. https://​doi.​org/​10.​1016/​j.​jchromb.​2014.​10.​028 CrossRef
36.
go back to reference Meyer MR, Dinger J, Schwaninger AE, Wissenbach DK, Zapp J, Fritschi G, Maurer HH (2012) Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)). Anal Bioanal Chem 402:1249–1255. https://doi.org/10.1007/s00216-011-5528-8 CrossRefPubMed Meyer MR, Dinger J, Schwaninger AE, Wissenbach DK, Zapp J, Fritschi G, Maurer HH (2012) Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)). Anal Bioanal Chem 402:1249–1255. https://​doi.​org/​10.​1007/​s00216-011-5528-8 CrossRefPubMed
37.
go back to reference Steuer AE, Williner E, Staeheli SN, Kraemer T (2017) Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS). Drug Test Anal 9(7):1085–1092CrossRefPubMed Steuer AE, Williner E, Staeheli SN, Kraemer T (2017) Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS). Drug Test Anal 9(7):1085–1092CrossRefPubMed
39.
go back to reference Seeger E. Pykrolidino ketones. Patent US; 1967/3314970 A Seeger E. Pykrolidino ketones. Patent US; 1967/3314970 A
40.
go back to reference Uchiyama N, Shimokawa Y, Kawamura M, Kikura-Hanajiri R, Hakamatsuka T (2014) Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products. Forensic Toxicol 32(2):266–281. https://doi.org/10.1007/s11419-014-0238-5 CrossRef Uchiyama N, Shimokawa Y, Kawamura M, Kikura-Hanajiri R, Hakamatsuka T (2014) Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products. Forensic Toxicol 32(2):266–281. https://​doi.​org/​10.​1007/​s11419-014-0238-5 CrossRef
41.
go back to reference Paul M, Bleicher S, Guber S, Ippisch J, Polettini A, Schultis W (2015) Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). J Mass Spectrom 50(11):1305–1317. https://doi.org/10.1002/jms.3642 Erratum in: J Mass Spectrom 2016 51(4):322CrossRefPubMed Paul M, Bleicher S, Guber S, Ippisch J, Polettini A, Schultis W (2015) Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). J Mass Spectrom 50(11):1305–1317. https://​doi.​org/​10.​1002/​jms.​3642 Erratum in: J Mass Spectrom 2016 51(4):322CrossRefPubMed
46.
go back to reference Short SA, Schultz J, Lawler E, Wells K (2016) Postmortem cases involving fentanyl derivatives and U-47700. Toxtalk 40(4):11–13 Short SA, Schultz J, Lawler E, Wells K (2016) Postmortem cases involving fentanyl derivatives and U-47700. Toxtalk 40(4):11–13
47.
go back to reference McIntyre IM, Gary RD, Joseph S, Stabbley R (2017) A fatality related to the synthetic opioid U-47700: postmortem concentration distribution. J Anal Toxicol 41(2):158–160PubMed McIntyre IM, Gary RD, Joseph S, Stabbley R (2017) A fatality related to the synthetic opioid U-47700: postmortem concentration distribution. J Anal Toxicol 41(2):158–160PubMed
48.
go back to reference Kapil RP, Friedman K, Cipriano A, Michels G, Shet M, Mondal SA, Harris SC (2015) Effects of paroxetine, a CYP2D6 inhibitor, on the pharmacokinetic properties of hydrocodone after coadministration with a single-entity, once-daily, extended-release hydrocodone tablet. Clin Ther 37(10):2286–2296. https://doi.org/10.1016/j.clinthera.2015.08.007 Kapil RP, Friedman K, Cipriano A, Michels G, Shet M, Mondal SA, Harris SC (2015) Effects of paroxetine, a CYP2D6 inhibitor, on the pharmacokinetic properties of hydrocodone after coadministration with a single-entity, once-daily, extended-release hydrocodone tablet. Clin Ther 37(10):2286–2296. https://​doi.​org/​10.​1016/​j.​clinthera.​2015.​08.​007
Metadata
Title
Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700
Authors
Camille Richeval
Jean-Michel Gaulier
Ludovic Romeuf
Delphine Allorge
Yvan Gaillard
Publication date
01-01-2019
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Legal Medicine / Issue 1/2019
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-018-1969-3

Other articles of this Issue 1/2019

International Journal of Legal Medicine 1/2019 Go to the issue